Among the 180 genes selected in our initial target prioritization strategy, SNX10 was one of the top genes for which high expression was associated with poor patient prognosis in the TCGA glioblastoma data set (Figure 12D) and was upregulated in all subtypes of GSCs compared with NSCs (Figure 12E). This evidence concerns the gene SNX10 and glioblastoma.